Gene therapy: Potential applications in clinical transplantation

Expert Reviews in Molecular Medicine

Volumn 1, Issue 11, 1999, Pages 1-20

  Wood, Kathryn J ^a   Fry, Jeremy ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

bone marrow; gene therapy; intrathymic; rejection; tolerance; transplantation; vector

Indexed keywords

EID: 85012512139     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399499000691     Document Type: Article

References (86)

1. Turvey, S.E., Fry, J.W. and Wood, K.J. (1999) New insights on the mechanisms of acquired intrathymic tolerance. Current Opinion in Organ Transplantation 4, 50–57
2. Crystal, R.G. (1995) Transfer of genes to humans: early lessons and obstacles to success. Science 270, 404–410, PubMed ID:96026347
3. Haskova, V. and Hrubesova, M. (1958) Part played by deoxyribonucleic acid in transplantation immunity. Nature 182, 61–62
4. Medawar, P. (1958) Part played by deoxyribonucleic acid in transplantation immunity. Nature 182, 62
5. Geissler, E.K. et al. (1994) Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. J Immunol 152, 413–421, PubMed ID:94110595
6. Morris, P.J. (1997) Transplantation. In Encyclopaedia of Immunology (Delves, P.J. and Roitt, I.M., eds) (2nd edn), Academic Press, Vol. 4, pp. 2411–2415
7. Man, S. (1998) Human cellular immune responses against human papillomaviruses in cervical neoplasia. http://www-ermm.cbcu. cam.ac.uk/smc/txt001smc.htm
8. Billingham, R.E., Brent, L. and Medawar, P.B. (1953) Actively acquired tolerance of foreign cells. Nature 172, 603–606
9. Madsen, J.C. et al. (1988) Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 332, 161–164, PubMed ID:88156933
10. Wong, W. et al. (1997) Retroviral gene transfer of a donor class I MHC gene to recipient bone marrow cells induces tolerance to alloantigens in vivo. Transplant Proc 29, 1130, PubMed ID:97232737
11. Davies, H.S. et al. (1989) Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 47, 524–527, PubMed ID:89162769
12. Geissler, E.K., Korzun, W.J. and Graeb, C. (1997) Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responses. Transplantation 64, 782–786, PubMed ID:97456409
13. Zavazava, N. and Kronke, M. (1996) Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes [published erratum appears in Nat Med 1996 Nov;2(11):1267]. Nat Med 2, 1005–1010, PubMed ID:96376351
14. DeBruyne, L.A. et al. (1998) Lipid-mediated transfer of viral Il-10 prolongs vascularised cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Therapy 5, 1079–1087
15. Qin, L., Ding, Y. and Bromberg, J.S. (1996) Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum Gene Ther 7, 1981–1988, PubMed ID:97084314
16. Kita, Y. et al. (1998) Prolonged rat cardiac allograft survival using adenoviral vector containing the CTLA4Ig gene. Transplant Proc 30, 1079–1080, PubMed ID:98300066
17. Chahine, A.A. et al. (1995) Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells. Transplantation 59, 1313–1318, PubMed ID:95282245
18. Nagano, H. and Tilney, N.L. (1997) Chronic allograft failure: the clinical problem. Am J Med Sci 313, 305–309, PubMed ID:97290384
19. Haug, C.E. et al. (1993) A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55, 766–772
20. Shears, L.L., et al. (1998) Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J Am Coll Surg 187, 295–306, PubMed ID:98410903
21. Stepkowski, S.M. et al. (1998) Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides. Transplantation 66, 699–707, PubMed ID:98442775
22. Poston, R.S. et al. (1998) Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allografts. J Thorac Cardiovasc Surg 116, 386–396, PubMed ID:98400505
23. von der Leyen, H.E. et al. (1995) Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 92, 1137–1141, PubMed ID:95166784
24. Danel, C. et al. (1998) Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum Gene Ther 9, 1487–1496, PubMed ID:98344745
25. Fulton, G.J. et al. (1997) Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts [published erratum appears in J Vasc Surg 1997 Jul; 26(1):23]. J Vasc Surg 25, 453–463, PubMed ID:97236214
26. Pitsch, R.J. et al. (1996) Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb. J Vasc Surg 23, 783–791, PubMed ID:96225407
27. Jarvis, T.C. et al. (1996) Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA. Rna 2, 419–428, PubMed ID:96238828
28. Castier, Y. et al. (1998) The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is nonspecific. J Cardiovasc Surg (Torino) 39, 1–7, PubMed ID:98196876
29. Cech, T.R., Zaug, A.J. and Grabowski, P.J. (1981) In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell 27, 487–496, PubMed ID:93358321
30. Christoffersen, R.E. and Marr, J.J. (1995) Ribozymes as human therapeutic agents. J Med Chem 38, 2023–2037
31. Burke, J.M. (1996) Hairpin ribozyme: current status and future prospects. Biochem Soc Trans 24, 608–615, PubMed ID:97033066
32. Cech, T.R. (1987) The chemistry of self-splicing RNA and RNA enzymes. Science 236, 1532–1539, PubMed ID:87234350
33. Usman, N. and Stinchcomb, D.T. (1996) Design, synthesis, and function of therapeutic hammerhead ribozymes. Nucl. Acids Mol. Biol. 10, 243–264
34. Hayashi, S. et al. (1997) Effect of antisense ribozyme to alpha (1,3)galactosyl transferase gene on the expression of Gal alpha (1,3)Gal epitope. Transplant Proc 29, 893, PubMed ID:97232626
35. Du, Z. et al. (1997) In vitro characterization of hammerhead ribozymes against perforin and fas-ligand RNA. Transplant Proc 29, 2224–2225, PubMed ID:97336856
36. Posselt, A.M. et al. (1990) Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 249, 1293–1295, PubMed ID:90378303
37. Knechtle, S.J. et al. (1994) Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation 57, 990–996, PubMed ID:94218991
38. Knechtle, S.J. et al. (1997) Direct MHC class I complementary DNA transfer to thymus induces donor- specific unresponsiveness, which involves multiple immunologic mechanisms. J Immunol 159, 152–158, PubMed ID:97343923
39. Ilan, Y. et al. (1996) Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. J Clin Invest 98, 2640–2647, PubMed ID:97117160
40. Chia, S.H. et al. (1998) Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity. Transplantation 66, 1545–1551, PubMed ID:99084443
41. Shaked, A. et al. (1994) Retroviral-mediated gene transfer into rat experimental liver transplant. Transplantation 57, 32–34, PubMed ID:94120579
42. Nakauchi, H. (1998) Hematopoietic stem cells: are they CD34-positive or CD34-negative? Nat Med 4, 1009–1010, PubMed ID:98403459
43. Brenner, M.K. et al. (1994) Gene transfer and bone marrow transplantation. Cold Spring Harb Symp Quant Biol 59, 691–697, PubMed ID:96063144
44. Sykes, M. et al. (1993) Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 55, 197–202, PubMed ID:93127235
45. Fritz, Z. (1996) Retroviral vectors for gene transfer. http://www.mc.vanderbilt.edu/gcrc/ gene/retro.htm
46. Kwok, W.W. et al. (1986) Retroviral transfer of genes into canine hemopoietic progenitor cells in culture: a model for human gene therapy. Proc Natl Acad Sci U S A 83, 4552–4555, PubMed ID:86233465
47. Dzierzak, E.A., Papayannopoulou, T. and Mulligan, R.C. (1988) Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature 331, 35–41, PubMed ID:88122535
48. Luskey, B.D. et al. (1990) Gene transfer into murine hematopoietic stem cells and bone marrow stromal cells. Ann N Y Acad Sci 612, 398–406, PubMed ID:91150946
49. Bagley, J. et al. (1998) Long-term expression of the gene encoding green fluorescent protein in murine hematopoietic cells using retroviral gene transfer. Transplantation 65, 1233–1240, PubMed ID:98264312
50. Chu, P. et al. (1998) Retrovirus-mediated gene transfer into human hematopoietic stem cells. J Mol Med 76, 184–192, PubMed ID:98195229
51. Miller, A.D. et al. (1993) Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217, 581–599, PubMed ID:93233494
52. Miller, A.D. (1992) Human gene therapy comes of age. Nature 357, 455–460, PubMed ID:92301529
53. Sorrentino, B.P. et al. (1992) Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257, 99–103, PubMed ID:92320306
54. Sadaie, M.R. et al. (1998) Towards developing HIV-2 lentivirus-based retroviral vectors for gene therapy: dual gene expression in the context of HIV-2 LTR and Tat. J Med Virol 54, 118–128, PubMed ID:98157455
55. Goldman, M.J. et al. (1997) Lentiviral vectors for gene therapy of cystic fibrosis. Hum Gene Ther 8, 2261–2268, PubMed ID:98109433
56. Blomer, U. et al. (1997) Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 71, 6641–6649, PubMed ID:97404674
57. Rowe, W.P. et al. (1953) Isolation of a cytopathic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 84, 570–573
58. Lee, M.G. (1996) Adenovirus as Vectors for Gene Therapy. In Targeting of Drugs 5: Strategies for Oligonucleotide and Gene Delivery in Therapy (Gregoriadis, G. and McCormack, B., eds), pp. 53–64, Plenum Press, New York
59. Shenk, T. (1996) Adenoviridae: The Viruses and Their Replication. In Fundamental Virology (3rd edn) (Fields, B.N. et al., eds), pp. 979–1016, Lippincott - Raven Publishers, Philadelphia
60. Liu, F. and Green, M.R. (1994) Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature 368, 520–525, PubMed ID:94187874
61. Halbert, D.N., Cutt, J.R. and Shenk, T. (1985) Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J Virol 56, 250–257, PubMed ID:85293229
62. Wang, Q. et al. (1997) Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector. Gene Ther 4, 393–400, PubMed ID:97420211
63. Csete, M.E. et al. (1994) Adenovirus-mediated gene transfer in the transplant setting. I. Conditions for expression of transferred genes in cold-preserved hepatocytes. Transplantation 57, 1502–1507, PubMed ID:94255938
64. Gilgenkrantz, H. et al. (1995) Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum Gene Ther 6, 1265–1274, PubMed ID:96121552
65. Yang, Y. and Wilson, J.M. (1995) Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J Immunol 155, 2564–2570, PubMed ID:95378679
66. Tripathy, S.K. et al. (1996) Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2, 545–550, PubMed ID:96206278
67. DeMatteo, R.P. et al. (1997) Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. J Virol 71, 5330–5335, PubMed ID:97332368
68. Kolls, J.K. et al. (1996) Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. Hum Gene Ther 7, 489–497, PubMed ID:96236788
69. Stein, C.S. et al. (1998) Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus. Gene Ther 5, 431–439, PubMed ID:98276750
70. Guerette, B. et al. (1996) Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. Hum Gene Ther 7, 1455–1463, PubMed ID:97001213
71. Dong, Z., Yang, X. and Fidler, I.J. (1997) Neutralization of endogenous interferon-beta increases the efficiency of adenoviral vector-mediated gene transduction. J Interferon Cytokine Res 17, 401–407, PubMed ID:97387339
72. Mizuno, M. et al. (1998) Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration. Jpn J Cancer Res 89, 76–80, PubMed ID:98169301
73. Linden, R.M. et al. (1996) Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A 93, 11288–11294, PubMed ID:97030187
74. Halbert, C.L. et al. (1995) Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 69, 1473–1479, PubMed ID:95156571
75. Goins, W.F. et al. (1997) Herpes simplex virus vectors for gene transfer to the nervous system. J Neurovirol 3 Suppl 1, S80–88, PubMed ID:97323314
76. Latchman, D.S. (1994) Herpes simplex virus vectors for gene therapy. Mol Biotechnol 2, 179–195, PubMed ID:95171254
77. Peplinski, G.R., Tsung, K. and Norton, J.A. (1998) Vaccinia virus for human gene therapy. Surg Oncol Clin N Am 7, 575–588, PubMed ID:98289125
78. Lattime, E.C. et al. (1996) In situ cytokine gene transfection using vaccinia virus vectors. Semin Oncol 23, 88–100, PubMed ID:96181907
79. Felgner, J.H. et al. (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269, 2550–2561, PubMed ID:94132017
80. Gao, X. and Huang, L. (1995) Cationic liposome-mediated gene transfer. Gene Ther 2, 710–722, PubMed ID:96342119
81. Dzau, V.J. et al. (1996) Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc Natl Acad Sci U S A 93, 11421–11425, PubMed ID:97030209
82. Curiel, D.T. et al. (1992) High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Hum Gene Ther 3, 147–154, PubMed ID:93003508
83. Qin, L. et al. (1997) Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther 8, 2019–2029, PubMed ID:98075062
84. Harms, J.S. and Splitter, G.A. (1995) Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum Gene Ther 6, 1291–1297, PubMed ID:96121555
85. Gribaudo, G. et al. (1993) Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197, 303–311, PubMed ID:94025578
86. Benhamou, P.Y. et al. (1996) Decreased alloreactivity to human islets secreting recombinant viral interleukin 10. Transplantation 62, 1306–1312, PubMed ID:97086588